Atlas Trials

Efficacy and Safety of Tirzepatide Versus Placebo or Lisdexamfetamine Dimesylate for Binge-Eating Disorder

Clinical trial NCT06847399 · RECRUITING

Trial details

NCT number
NCT06847399
Sponsor
Johns Hopkins University
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Obesity and OverweightBinge Eating Disorder
Start date
2025-09-17
Primary completion
2027-12-01
Enrollment
105

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.